Understanding anti-leukemia responses to donor lymphocyte infusion

Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachireddy, Pavan, Wu, Catherine J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2014
Materias:
Author's View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203631/
https://www.ncbi.nlm.nih.gov/pubmed/25340010
http://dx.doi.org/10.4161/onci.28187
_version_ 1782340413718265856
author Bachireddy, Pavan
Wu, Catherine J
author_facet Bachireddy, Pavan
Wu, Catherine J
author_sort Bachireddy, Pavan
collection PubMed
description Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti-leukemia immunity.
format Online
Article
Text
id pubmed-4203631
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-42036312015-03-17 Understanding anti-leukemia responses to donor lymphocyte infusion Bachireddy, Pavan Wu, Catherine J Oncoimmunology Author's View Donor lymphocyte infusion (DLI) is an established and potentially curative immune therapy for relapsed leukemia after hematopoietic stem cell transplant (HSCT). Herein, we describe the utility of DLI as a tractable model system to glean fresh insights into understanding and predicting effective anti-leukemia immunity. Landes Bioscience 2014-03-17 /pmc/articles/PMC4203631/ /pubmed/25340010 http://dx.doi.org/10.4161/onci.28187 Text en Copyright © 2014 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Author's View
Bachireddy, Pavan
Wu, Catherine J
Understanding anti-leukemia responses to donor lymphocyte infusion
title Understanding anti-leukemia responses to donor lymphocyte infusion
title_full Understanding anti-leukemia responses to donor lymphocyte infusion
title_fullStr Understanding anti-leukemia responses to donor lymphocyte infusion
title_full_unstemmed Understanding anti-leukemia responses to donor lymphocyte infusion
title_short Understanding anti-leukemia responses to donor lymphocyte infusion
title_sort understanding anti-leukemia responses to donor lymphocyte infusion
topic Author's View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203631/
https://www.ncbi.nlm.nih.gov/pubmed/25340010
http://dx.doi.org/10.4161/onci.28187
work_keys_str_mv AT bachireddypavan understandingantileukemiaresponsestodonorlymphocyteinfusion
AT wucatherinej understandingantileukemiaresponsestodonorlymphocyteinfusion

Ejemplares similares